Precigen Inc (NASDAQ:PGEN) has a beta value of 1.70 and has seen 0.48 million shares traded in the recent trading session. The PGEN stock price is -45.64% off its 52-week high price of $2.17 and 56.38% above the 52-week low of $0.65. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.42 million shares traded. The 3-month trading volume is 1.93 million shares.
The consensus among analysts is that Precigen Inc (PGEN) is Buy stock at the moment, with a recommendation rating of 1.80. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.08.
Precigen Inc (NASDAQ:PGEN) trade information
Over the past 30 days, the shares of Precigen Inc (NASDAQ:PGEN) have changed -10.78%. Short interest in the company has seen 22.66 million shares shorted with days to cover at 12.62.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 75.17% from the levels at last check today. The projected low price target is $6.0 while the price target rests at a high of $6.0. In that case, then, we find that the latest price level in today’s session is -302.68% off the targeted high while a plunge would see the stock gain -302.68% from the levels at last check today.
Precigen Inc (PGEN) estimates and forecasts
The company’s shares have gained 57.42% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 309.17%.
3 analysts offering their estimates for the company have set an average revenue estimate of 600k for the current quarter. 3 have an estimated revenue figure of 600k for the next ending quarter. Year-ago sales stood 1.06M and 717k respectively for this quarter and the next, and analysts expect sales will shrink by -43.66% for the current quarter and 309.17% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 25.76% over the past 5 years.
PGEN Dividends
Precigen Inc is expected to release its next earnings report on 2025-Mar-18 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Precigen Inc (NASDAQ:PGEN)’s Major holders
Insiders own 9.97% of the company shares, while shares held by institutions stand at 66.12% with a share float percentage of 73.44%. Investors are also buoyed by the number of investors in a company, with Precigen Inc having a total of 174.0 institutions that hold shares in the company. The top two institutional holders are PATIENT CAPITAL MANAGEMENT, LLC with over 18.17 million shares worth more than $28.72 million. As of 2024-06-30, PATIENT CAPITAL MANAGEMENT, LLC held 7.2017% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 10.25 million shares as of 2024-06-30. The firm’s total holdings are worth over $16.19 million and represent 4.0604% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Advisor Managed Portfolios-Patient Opportunity Trust and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 4.90% shares in the company for having 14.4 shares of worth $21.17 million while later fund manager owns 5.45 shares of worth $8.02 million as of Dec 31, 2024, which makes it owner of about 1.85% of company’s outstanding stock.
